From design to the clinic: practical guidelines for translating cardiovascular nanomedicine

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiology

Background:

• Cardiovascular diseases (CVD) are a leading cause of death globally and in Europe.
• Rising rates of aging, obesity, and diabetes are predicted to increase CVD mortality.
• Cardiovascular nanomedicine offers potential solutions using nanoscale products.

Purpose of the Study:

• To review the rational design of nanoparticles for cardiovascular applications.
• To discuss safety considerations and regulatory challenges in nanomedicine development.
• To highlight pathways for efficient clinical translation of nanomedicinal products.

Main Methods:

• Literature review of current research in cardiovascular nanomedicine.
• Analysis of technical, ethical, and regulatory hurdles.
• Discussion of design principles for nanoparticles.

Main Results:

• Nanomedicine faces significant challenges in clinical translation.
• Rational design and safety assessments are crucial for nanoparticle development.
• Addressing regulatory issues is key for therapeutic advancement.

Conclusions:

• Successful clinical translation of cardiovascular nanomedicine requires careful design and safety evaluation.
• Overcoming technical and regulatory barriers is essential for reducing CVD burden.
• This review provides insights into navigating the path from nanomedical product development to clinical practice.